Epidemiologic evidence for different roles of ultraviolet A and B radiation in melanoma mortality rates

Annals of Epidemiology

Volumn 13, Issue 6, 2003, Pages 395-404

  Garland, Cedric F ^a,b   Garland, Frank C ^a,b   Gorham, Edward D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

Epidemiology; International comparisons; Malignant melanoma; Mortality rates; Ultraviolet A; Ultraviolet B

Indexed keywords

ARTICLE; ASIA; AUSTRALIA AND NEW ZEALAND; CONTROLLED STUDY; EUROPE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MORTALITY; NORTH AMERICA; OZONE LAYER; POPULATION RESEARCH; PRIORITY JOURNAL; SEX RATIO; SKIN PIGMENTATION; SOUTH AMERICA; STRATOSPHERE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; WORLD HEALTH ORGANIZATION;

EID: 0037823197     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(02)00461-1     Document Type: Article

References (61)

1. American Cancer Society Cancer facts and figures, 2003. 2003;American Cancer Society, Atlanta.
2. Hall H., Miller D., Rogers J., Bewerse B. Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol. 40:1999;35-42.
3. Manson J., Rexrode K., Garland F., Garland C., Weinstock M. The case for a comprehensive national campaign to prevent melanoma and associated mortality. Epidemiology. 11:2000;728-734.
4. Elwood J. Melanoma and sun exposure. Semin Oncol. 23:1996;650-666.
5. Katsambas A., Nicolaidou E. Cutaneous malignant melanoma and sun exposure. recent developments in epidemiology Arch Dermatol. 132:1996;444-450.
6. Eller M., Maeda T., Magnini C., Altwal D., Gilchrest B. Enhancement of DNA repair in human skin cells by thymidine dinucleotides. evidence for a p53-mediated mammalian SOS response P Natl Acad Sci USA. 94:1997;12627-12632.
7. Cristofolini M., Franceschi S., Tasin L., Zumiani G., Piscioli F., Talamini R.et al. Risk factors for cutaneous malignant melanoma in a Northern Italian population. Int J Cancer. 39:1987;150-154.
8. Garland F., White M., Garland C., Shaw E., Gorham E. Occupational sunlight exposure and melanoma in the US Navy. Arch Environ Health. 45:1990;261-267.
9. Franceschi S., La Vecchia C., Lucchini F., Cristofolini M. The epidemiology of cutaneous malignant melanoma. aetiology and European data Eur J Cancer Prev. 1(1):1991;9-22.
10. Lee J. Melanoma and exposure to sunlight. Epidemiol Rev. 4:1982;110-136.
11. Pickle L, Mason T, Howard N, Hoover R, Fraumeni J Jr. Atlas of US cancer mortality among whites: 1950-1980. Bethesda, MD: National Cancer Institute; 1987: 52-56 (DHHS Publication No. (NIH) 87-2900).
12. Garland C., Garland F., Gorham E. Rising trends in melanoma. an hypothesis concerning sunscreen effectiveness Ann Epidemiol. 3:1993;103-110.
13. Wang S.Q., Setlow R., Berwick M., Polsky D., Marghoob A.A., Kopf A.W.et al. Ultraviolet A and melanoma. a review J Am Acad Dermatol. 44(5):2001;837-846.
14. Knox J., Griffin A., Hakim H. Protection from ultraviolet carcinogenesis. J Invest Dermatol. 34:1960;51-57.
15. Kligman L., Akin F., Kligman A. Sunscreens prevent ultraviolet carcinogenesis. J Am Acad Dermatol. 3:1980;30-35.
16. Garland F, Gorham E, Garland C. Sunlight, vitamin D, and cancer: possible hazards of pharmacological sunscreens. In: National Institute of Arthritis, Musculoskeletal, and Skin Diseases. Consensus Conference on Effects of Ultraviolet Radiation on the Skin; May 8-10, 1989. Bethesda, MD; 1989.
17. Setlow R., Grist E., Thompson K., Woodhead A. Wavelengths effective in induction of malignant melanoma. Proc Natl Acad Sci USA. 90:1993;6666-6670.
18. Setlow R., Woodhead A. Temporal changes in the incidence of malignant melanoma. explanation from action spectra Mutat Res. 307:1994;365-374.
19. Autier P., Dore J.F., Schifflers E., Cesarini J.P., Bollaerts A., Koelmel K.F.et al. Melanoma and use of sunscreens. an EORTC case-control study in Germany, Belgium and France. The EORTC Melanoma Cooperative Group Int J Cancer. 61(6):1995;749-755.
20. Lim HW, Naylor M, Hönigsman H, Gilchrest BA, Cooper K, Morison W, et al. American Academy of Dermatology Consensus Conference on UVA protection of sunscreens: Summary and recommendations. J Am Acad Dermatol. 2001;44:505-508.
21. Mount G., Rottman G. The solar absolute spectral irradiance 1150-3173 Å J Geophys Res. 88:1983;5403-5410.
22. Green A., Sawada T., Shettle E. The middle ultraviolet reaching the ground. Photochem Photobiol. 19:1974;251-259.
23. Frederick J., Lubin D. The budget of biologically active ultraviolet radiation in the earth-atmosphere system. J Geophys Res. 93:1988;3825-3832.
24. Miller S., Hamilton S., Wester U., Cyr W. An analysis of UVA emissions from sunlamps and their potential importance for melanoma. Photochem Photobiol. 68:1998;63-70.
25. Armstrong B. Descriptive epidemiology of skin cancer. Grob J., Stern R., MacKie R., Weinstock M. Epidemiology, Causes and Prevention of Skin Diseases. 1997;41-47 Blackwell Science, Oxford.
26. US National Center for Health Statistics Vital statistics of the United States, 1955. Mortality, Part A:1959;US Government Printing Office, Washington, DC.
27. Marks R. Epidemiology of melanoma. Clin Exp Dermatol. 25:2000;459-463.
28. Evans R., Kopf A., Lew R.et al. Risk factors for the development of malignant melanoma. I. Reviews of case-control studies J Dermatol Surg Oncol. 14:1988;383-406.
29. Cress R., Holly E., Ahn D. Cutaneous melanoma in Women. V. Characteristics of those who tan and those who burn when exposed to summer sun Epidemiology. 6:1995;538-543.
30. Beral V., Evans S., Shaw H., Milton G. Cutaneous factors related to the risk of malignant melanoma. Br J Dermatol. 109:1983;165-172.
31. Holman C., Armstrong B. Pigmentary traits, ethnic origin, benign nevi and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst. 72:1984;257-266.
32. Kricker A, Armstrong B, Jones M, Burton R. Health, solar radiation, and environmental change - IARC Technical Report No. 13. Lyon, France: International Agency for Research on Cancer; 1993.
33. Armstrong B., Kricker A. Cutaneous melanoma. Cancer Surv. 19:1994;219-240.
34. Garland C., Garland F., Gorham E. Could sunscreens increase melanoma risk? Am J Public Health. 82:1992;614-615.
35. Setlow R. Spectral regions contributing to melanoma. a personal view J Investig Dermatol Symp Proc. 4(1):1999;46-49.
36. Snyder D., May M. Ability of PABA to protect mammalian skin from ultraviolet light-induced skin tumors and actinic damage. J Invest Dermatol. 65:1975;543-546.
37. Flindt-Hansen H., Thune P., Eeg-Larsen T. The effect of short-term application of PABA on photocarcinogenesis. Acta Derm-Venereol. 70:1990;72-75.
38. Wikonkal N.M., Brash D.E. Ultraviolet radiation induced signature mutations in photocarcinogenesis. J Investig Dermatol Symp Proc. 4(1):1999;6-10.
39. Hadshiew I., Eller M., Moll I., Gilchrest B. Photoprotective mechanisms of human skin. Modulation by oligonucleotides Hautarzt. 53:2002;167-173.
40. Garland C., Garland F., Gorham E. Lack of efficacy of common sunscreens in melanoma prevention. Grob J., Stern R., MacKie R., Weinstock M. Epidemiology, Causes and Prevention of Skin Disease. 1997;151-158 Blackwell Science, Oxford.
41. Lubin D., Jensen E., Gies P. Global surface ultraviolet radiation climatology from TOMS and ERBE data. J Geophys Res. 103(D20):1998;26,061-26,091.
42. Jablonski N., Chaplin G. The evolution of human skin coloration. J Hum Evol. 39:2000;57-106.
43. Autier P., Dore J.F., Cattaruzza M.S., Renard F., Luther H., Gentiloni-Silverj F.et al. Sunscreen use, wearing clothes, and number of nevi in 6- to 7-year-old European children. European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. J Natl Cancer Inst. 90(24):1998;1873-1880.
44. Gallagher R.P., Rivers J.K., Lee T.K., Bajdik C.D., McLean D.I., Coldman A.J. Broad-spectrum sunscreen use and the development of new nevi in white children. A randomized controlled trial JAMA. 283(22):2000;2955-2960.
45. Pearse A., Gaskell S., Marks R. Epidermal changes in human skin following irradiation with either UVB or UVA. J Invest Dermatol. 88:1987;83-87.
46. Kaidbey K., Agin P., Sayre R., Kligman A. Photoprotection by melanin-a comparison of black and caucasian skin. J Am Acad Dermatol. 1:1979;249-260.
47. Klepp O., Magnus K. Some environmental and bodily characteristics of melanoma patients. a case-control study Int J Cancer. 23:1979;482-486.
48. Graham S., Marshall J., Haughey B.et al. An inquiry into the epidemiology of melanoma. Am J Epidemiol. 122:1985;606-619.
49. Holman C., Armstrong B., Heenan P. Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst. 76:1986;403-414.
50. Beitner H., Norell S., Ringborg U.et al. Malignant melanoma. aetiological importance of individual pigmentation and sun exposure Br J Dermatol. 122:1990;43-51.
51. Herzfeld P., Fitzgerald E., Hwang S.-A., Stark A. A case-control study of malignant melanoma of the trunk among white males in upstate New York. Cancer Detect Prev. 17:1993;601-608.
52. Westerdahl J., Olsson H., Masbach A.et al. Is the use of sunscreens a risk factor for malignant melanoma? Melanoma Res. 5:1995;59-65.
53. Wolf P., Quehenberger F., Mullegger R., Stranz B., Keri B. Phenotypic markers, sunlight-related factors and sunscreen use in patients with cutaneous melanoma. An Austrian case-control study Melanoma Res. 8(4):1998;370-378.
54. Hunter D., Colditz D., Stampfer M.et al. Risk factors for basal cell carcinoma in a prospective cohort study of women. Ann Epidemiol. 1:1990;13-23.
55. Grodstein F., Speizer F.E., Hunter D. A prospective study of incident squamous cell cancer of the skin in the Nurses' Health Study. J Natl Cancer Inst. 87:1995;1061-1066.
56. Rodenas J.M., Delgado-Rodriguez M., Herranz M.T., Tercedor J., Serrano S. Sun exposure, pigmentary traits, and risk of cutaneous malignant melanoma. a case-control study in a Mediterranean population Cancer Causes Control. 7(2):1996;275-283.
57. Arranz J., Hernandez J., Fernandez P.et al. Cutaneous malignant melanoma and sun exposure in Spain. Melanoma Res. 9:1999;199-205.
58. Holly E., Aston D., Cress R., Ahn D., Kristiansen J. Cutaneous melanoma in women. I. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light Am J Epidemiol. 141(10):1995;923-933.
59. Ley R. Dose-response for ultraviolet radiation-A-induced focal melanocytic hyperplasia and non-melanoma skin tumors in monodelphis domestica. Photochem Photobiol. 73:2001;20-23.
60. Evans S.R., Houghton A.M., Schumaker L., Brenner R.V., Buras R.R., Davoodi F.et al. Vitamin D receptor and growth inhibition by 1,25-dihydroxyvitamin D3 in human malignant melanoma cell lines. J Surg Res. 61:1996;127-133.
61. Hutchinson P.E., Osborne J.E., Lear J.T., Smith A.G., Bowers P.W., Morris P.N.et al. Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin Cancer Res. 6:2000;498-504.